Loading clinical trials...

COMPLETED

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis

NCT05005650•Seoul National University Hospital

View on ClinicalTrials.gov

Summary

To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.

Eligibility

Age

18 - 90 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer
•Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm)
•Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer
•Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020
•Patients age 18-90

Exclusion Criteria

•Borderline or benign ovarian disease
•Patient didn't undergo debulking surgery
•Non-epithelial ovarian cancer

Locations (1)

Seoul National University Hospital

Seoul, 시/도/주, South Korea

Key Dates

Start Date

June 1, 2021

Primary Completion Date

August 31, 2021

Completion Date

December 31, 2021

Last Updated

June 26, 2023

Enrollment

121

ACTUAL participants

Conditions

Ovarian Cancer Stage IVLymph Node Metastases

Interventions

debulking surgery

PROCEDURE

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

NCT06290193

Ovarian CancerFallopian Tube Carcinoma+8 more

View study

RECRUITINGNA

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

NCT04744506

Breast CancerSurgery+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

Inclusion Criteria

Exclusion Criteria

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits

PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .

Sentinel Node in Larynx and Pharynx Cancers